Clinical implications of hepatitis C viral kinetics

Journal of Hepatology, Supplement

Volumn 31, Issue 1, 1999, Pages 61-64

  Zeuzem, Stefan ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

Hepatitis C virus dynamics; Induction therapy; Interferon alpha; Pegylated interferon alpha; Ribavirin; Viral turnover

Indexed keywords

ALPHA INTERFERON; RIBAVIRIN;

ANTIVIRAL ACTIVITY; CONFERENCE PAPER; DOSE RESPONSE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; KINETICS; MATHEMATICAL ANALYSIS; PRIORITY JOURNAL; VIREMIA; VIRUS LOAD; VIRUS REPLICATION;

EID: 0033404706     PISSN: 01695185     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0168-8278(99)80376-6     Document Type: Conference Paper

References (20)

1. Nguyen TT, Sedghi-Vaziri A, Wilkes LB, Mondala T, Pockros PJ, Lindsay KL et al. Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection. J Viral Hepatitis 1996: 3: 75-78.
2. Zeuzem S, Schmidt JM, Lee J-H, Rüster B, Roth WK. Effect of interferon alpha on the dynamics of hepatitis C virus turnover in viro. Hepatology 1996: 23: 366-371.
3. Zeuzem S, Schmidt JM, Lee J-H, von Wagner M, Teuber G, Roth WK. Hepatitis C virus dynamics in mo: effect of ribavirin and interferon alpha on viral turnover. Hepatology 1998: 28: 245252.
4. Neumann AU, Lam NP, Dahari H, Gretch DR, Wiley TE, Layden TJ, Perelson AS. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-or therapy. Science 1998:282: 103-107.
5. Yasui K, Okanoue T, Murakami Y, Itoh Y, Minami M, Sakamoto S et al. Dynamics of hepatitis C viremia following interferon-a administration. J Infect Dis 1998: 177:1475-1479.
6. Lam NP, Neumann AU, Gretch DR, Wiley TE, Perelson AS, Layden AJ. Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alpha. Hepatology 1997:26:226-231.
7. Bekkering FC, Brouwer JT, Schalm SW, Elewaut A. Hepatitis C: viral kinetics [letter]. Hepatology 1997: 26: 1691-1693.
8. Di Bisceglie AM, Conjeevaram HS, Fried MW, Sallie R, Park Y, Yurdaydin C et al. Ribavirin as therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1995: 123: 897-903.
9. Poynard T, Marcellin P, Lee SS, Niederau C, Minuk GS, Ideo G et al. for the International Hepatitis Interventional Therapy Group (IHIT). Randomised trial of Interferon cr2b plus ribavirin for 48 weeks or for 24 weeks versus interferon cr2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. Lancet 1998: 352: 1426-1432.
10. Davis GL, Esteban-Mur R, Rustgi V, Hoefs J, Gordon S, Trepo C et al. for the International Hepatitis Interventional Therapy Group (IHIT). Interferon alpha-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. N Engl J Med 1998: 339: 1493-1499.
11. McHutchinson JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK. et al. for the Hepatitis Interventional Therapy Group (HIT). Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 1998: 339: 1485-1492.
12. Tsiang M, Dale B, Rooney J, Toole JJ, Gibbs CS. Dynamics of hepatitis B virus clearance from the serum of patients treated with adefovir dipivoxil for 12 weeks. Hepatology 1998: 28 (suppl): 492A.
13. Fukumoto T, Berg T, Ku Y, Bechstein WO, Knoop M, Lemmens HP et al. Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions. Hepatology 1996: 24: 1351-1354.
14. Coffin JM. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 1995: 267: 483-489.
15. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 1995: 373: 123-126.
16. Wei X, Ghosh SK, Taylor ME, Johnson VA, Emini EA, Deutsch P et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995: 373: 117-122.
17. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. HIV-1 dynamics in vivo: virion clearance rate, infected cell lifespan, and viral generation time. Science 1996: 271: 1582-1586.
18. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996: 93: 4398-4402.
19. Stalgis C, McHutchison J, Bekkering F, Perelson AS. Prediction of early viral clearance with daily IFN+RIB using a mathematical model. Hepatology 1998: 28 (suppl): 398A.
20. Zeuzem S, Lee J-H, Franke A, Rüster B, Prümmer O, Herrmann G et al. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alpha. Hepatology 1998: 27: 1149-1156.